Japan· JP-6152401F1146
ミノサイクリン塩酸塩
A minocycline product containing ミノサイクリン塩酸塩, registered in Japan by 沢井製薬, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Minocycline is registered in 10 of 19 countries.
Countries holding a registration under ATC J01AA08 (minocycline), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 4 of them publish a price we can compare per daily dose
Minocycline · ATC J01AA08
10 / 19 countries
- Belgiumprice
- Canada
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ミノサイクリン塩酸塩
- Manufacturer
- 沢井製薬
- Country
- Japan (JP)
- ATC code
- J01AA08
- ATC class
- Minocycline
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
367 interactions on record for minocycline.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Minocycline · interactions on record
367 records
- 15 severe
- 142 moderate
- 28 minor
- 128 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- AcitretinD05BB02severe
- IsotretinoinD10AD04severe
54 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01AA08
Minocycline, as other registers publish it.
- United KingdomAcnamino MR 100mg capsulesAlmus Pharmaceuticals Ltd
- United KingdomAcnamino MR 100mg capsulesDexcel-Pharma Ltd
- United KingdomAknemin 100mg capsulesAlmirall Ltd
- United KingdomAknemin 50 capsulesAlmirall Ltd
- United StatesArestinOraPharma, Inc.
- United KingdomBlemix 100mg tabletsAshbourne Pharmaceuticals Ltd
- United KingdomBlemix 50mg tabletsAshbourne Pharmaceuticals Ltd
- United StatesEMROSIJourney Medical Corporation
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bfd63f3a-448b-42d1-a02b-2fb5e70c04f3 GET /v1/drugs/bfd63f3a-448b-42d1-a02b-2fb5e70c04f3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１００ｍｇ１瓶",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "6152401F1146",
"category": "注射薬",
"price_yen": 350,
"generic_name": "ミノサイクリン塩酸塩",
"product_name_jp": null,
"therapeutic_class": "6152",
"transitional_expiry": null
}See everything about minocycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.